Mecoprize P 75 Tablet SR
Marketer
Mnicro Labs Pvt. Ltd
Salt Composition
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Overview Mecoprize P 75 Tablet SR
Prizime 75mg Extended-Release Tablets are a prescription medication for managing neuropathic pain. They reduce pain signals by regulating calcium channel function within nerve cells. This medication also safeguards nerve fibers and promotes the repair of damaged nerve cells. Prizime 75mg Extended-Release Tablets are administered orally, with or without food, ideally before sleep. Consistent daily timing helps maintain stable drug levels. Follow your doctor's prescribed dosage and duration, as this medication can be habit-forming. If a dose is missed, take it as soon as possible. Complete the entire course of treatment, even with symptom improvement. Abrupt cessation should be avoided without consulting your physician. Common side effects may include upper respiratory infection, increased appetite, elevated mood, trembling, visual blurring, dry mouth, lightheadedness, and drowsiness. Avoid activities requiring alertness until the medication's effects are known. Side effects are generally mild and improve over time. Weight gain is possible; regular exercise and a balanced diet can help mitigate this. Report any unusual mood or behavioral changes, new or worsening depression, or suicidal thoughts to your doctor. Disclose all other medications being taken, as interactions may reduce efficacy or alter the drug's action. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding.
Uses of Mecoprize P 75 Tablet SR
Managing neuropathic pain
Major Benefits of Mecoprize P 75 Tablet SR:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mecoprize P 75 Tablet SR can be consumed with or without food, however, consistent timing is recommended.
Common Side effects of Mecoprize P 75 Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Mecoprize P 75 Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mecoprize P 75 Tablet SR can be consumed with or without food; however, consistent timing is recommended.
How Mecoprize P 75 Tablet SR works:
Mecoprize P 75 SR tablets contain methylcobalamin and pregabalin, working synergistically to manage neuropathic pain. Methylcobalamin, a vitamin B12 derivative, supports myelin sheath production, protecting and repairing nerve cells. Pregabalin, an alpha-2-delta calcium channel ligand, reduces pain signaling by modulating nerve cell calcium channel activity. This dual action provides effective relief from nerve damage-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Mecoprize P 75 Tablet SR and alcohol may result in significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Mecoprize P 75 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks before prescribing this medication. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Sustained-release Mecoprize P 75 tablets are likely unsuitable for breastfeeding mothers. Preliminary human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Mecoprize P 75 Tablet SR may cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Mecoprize P 75 Tablet SR cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Mecoprize P 75 Tablet SR in patients with liver conditions appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Mecoprize P 75 Tablet SR :
Should you forget a dose of Mecoprize P 75 Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mecoprize P 75 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |


